Clinical Trials List
2026-01-15 - 2031-03-31
Phase III
Not yet recruiting6
ICD-10C78.5
Secondary malignant neoplasm of large intestine and rectum
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9197.5
Secondary malignant neoplasm of large intestine and rectum
-
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/09/08
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Peng-Chan Lin 無
- 黃怡菁 無
- 黃盈慈 無
- 陳柏全 無
- 黃怡璇 無
- Shang-Hung Chen 無
- 鍾秉軒 無
- Po-Wen Lin 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Chueh-Chuan Yen 無
- 唐振育 無
- Yi-Ping Hung 無
- Chien-An Liu 無
- 姜乃榕 無
- Ming-Huang Chen 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Yung-Chia Kao 無
- Wen-Chi Chou 無
- Ming-Mo Hou 無
- Mengting Peng 無
- 呂嘉偉 無
- 黃文冠 無
- Jen-Shi Chen 無
- Chia-Hsun Hsieh 無
- 張境夫 無
- 賴盈傑 無
- 黃振洋 無
- 余紹銘 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 張琮琨 無
- 黃敬文 無
- Wei-Chih Su 無
- 蔡祥麟 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
113 participants
-
Global
800 participants
